Stocktoria

GLOBUS MEDICAL INC GMED

NYSE · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2012-03-08 · LEI

GLOBUS MEDICAL INC statistics & valuation

P / E21.8×
P / S4.0×
P / B2.6×
P / FCF19.9×
Net margin18.3%
FCF margin20.0%
Return on capital10%
Graham number -36.7%$54.25

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($54.25); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
18.50% 16.90% 21.90% 19.80% 13.00% 15.60% 18.60% 7.80% 4.10% 18.30% 2016201720182019202020212022202320242025
Gross margin (%)
76.10% 76.30% 77.60% 77.10% 72.40% 75.00% 74.20% 65.10% 2016201720182019202020212022202320242025
Operating margin (%)
27.30% 25.40% 23.70% 21.90% 14.10% 17.90% 22.30% 8.50% 6.60% 16.30% 2016201720182019202020212022202320242025
Return on equity (%)
12.50% 11.10% 13.20% 11.10% 6.80% 8.60% 10.30% 3.10% 2.50% 11.80% 2016201720182019202020212022202320242025
Shares outstanding
96.4M 97.9M 101.3M 102.0M 101.0M 103.6M 102.6M 114.6M 137.9M 137.1M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
11.20% 10.00% 12.00% 10.10% 6.10% 7.60% 9.20% 2.40% 2.00% 10.10% 2016201720182019202020212022202320242025
Free cash flow margin (%)
19.00% 16.90% 17.10% 12.90% 17.10% 22.90% 10.20% 10.50% 16.10% 20.00% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
$1.08 $1.10 $1.54 $1.52 $1.01 $1.44 $1.85 $1.07 $0.75 $3.92 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

GLOBUS MEDICAL INC trades at about 21.9× earnings — below its 10-year norm (10-year range 23.1×–123.6×, median 41.9×).

21.9× 123.6×

Shaded band = 10-year range (23.1×–123.6×); dot = today's 21.9×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin65.1%74.2%75.0%72.4%77.1%77.6%76.3%76.1%
Operating margin16.3%6.6%8.5%22.3%17.9%14.1%21.9%23.7%25.4%27.3%
Net margin18.3%4.1%7.8%18.6%15.6%13.0%19.8%21.9%16.9%18.5%
FCF margin20.0%16.1%10.5%10.2%22.9%17.1%12.9%17.1%16.9%19.0%
Return on assets10.1%2.0%2.4%9.2%7.6%6.1%10.1%12.0%10.0%11.2%
Return on equity11.8%2.5%3.1%10.3%8.6%6.8%11.1%13.2%11.1%12.5%
Current ratio4.262.544.886.186.176.806.176.566.676.43

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.